See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Feb. 2, 2007

Smoking Cessation Epilepsy Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Smoking Cessation

Researchers are looking for adult volunteers who want to quit smoking to participate in a clinical study of an investigational medication. Study participation, limited to people 18 and older, may last up to seven months. Compensation is available up to $400 for time and travel.

The research site is in Orlando, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat237.html.

-----

Epilepsy

People with epileptic refractory partial seizures may be eligible to participate in this study if they are between 18 and 80 years old and have been treated unsuccessfully with at least two other anti-epileptic drugs. Additional criteria may apply.

The research site is in New York City.

More information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

-----

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

This 14-week trial will evaluate children with attention deficit/hyperactivity disorder (ADHD). To be eligible, your child must be between ages 6 and 12, be in good health, meet criteria for ADHD, and have no skin allergies that would prohibit wearing a medicated patch.

The research site is in Norfolk, Va.

More information

Please see http://www.centerwatch.com/patient/studies/cat18.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.